Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Erasca, Inc (“Erasca” or the “Company”) (NASDAQ: ERAS) and reminds investors of the August 10, ...

Erasca (NasdaqGS:ERAS) is facing legal and intellectual property challenges after Revolution Medicines alleged patent infringement and trade secret misappropriation tied to ERAS-0015. The dispute ...

“Obviously, you guys know I’m a big fan of Taylor, and ‘The Eras Tour was the best concert of all time,” Clark said in her post-game press conference. “These are my last [player-exclusives] that I was ...

Erasca recently faced a legal challenge from competitor Revolution Medicines over alleged trade secret misappropriation and patent infringement tied to its lead oncology candidate ERAS-0015, prompting ...

Taylor Swift‘s The Eras Tour has broken numerous records: the first tour to gross over $1 billion, the highest-grossing concert film of all-time, the first tour to register a 2.3-magnitude earthquake, ...

Forbes contributors publish independent expert analyses and insights. Monica is an entertainment reporter covering TV, film, and music. KANSAS CITY, MISSOURI - JULY 07: (EDITORIAL USE ONLY. NO ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Taylor Swift played her last-ever Eras Tour concert on Sunday, December ...

On May 11, Erasca Inc. (NASDAQ:ERAS) announced a supply agreement and a clinical trial partnership with Merck.

Forbes contributors publish independent expert analyses and insights. Monica is an entertainment reporter covering TV, film, and music. PARIS, FRANCE - MAY 12: (EDITORIAL USE ONLY. NO BOOK COVERS.) ...